Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission, we hope you enjoy your experience

VGHCX Vanguard Health Care Inv

  • Fund
  • VGHCX
  • Price as of: Aug 16, 2019
  • $192.81 + $2.60 + 1.37%
  • Category
  • Health & Biotech Equities

VGHCX - Profile

Vitals

  • YTD Return 1.2%
  • 3 Yr Annualized Return -3.3%
  • 5 Yr Annualized Return -1.4%
  • Net Assets $44.3 B
  • Holdings in Top 10 39.9%

52 WEEK LOW AND HIGH

$192.81
$180.66
$229.26

Expenses

OPERATING RELATED FEES

  • Expense Ratio 0.34%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 16.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

STANDARD (TAXABLE)

$0

IRA

$3,000

Investment Themes

CATEGORY

Health & Biotech Equities
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return 1.2%
  • 3 Yr Annualized Total Return -3.3%
  • 5 Yr Annualized Total Return -1.4%
  • Capital Gain Distribution Frequency None
  • Net Income Ratio 1.12%
DIVIDENDS
  • Dividend Yield 1.2%
  • Dividend Distribution Frequency None

Fund Details

  • Legal Name Vanguard Health Care Fund
  • Fund Family Name Vanguard
  • Inception Date May 23, 1984
  • Shares Outstanding N/A
  • Share Class Inv
  • Currency USD
  • Domiciled Country United States
  • Manager Jean M. Hynes

Fund Description

The Vanguard Health Care Fund Investor Shares (VGHCX) offers investors low-cost exposure to domestic and foreign companies involved in various aspects of the health care industry, such as pharmaceutical firms, medical supply companies and research firms. Given its narrow focus, VGHCX is better suited for those investors looking to add complementary exposure to an already diversified portfolio.

The actively managed fund seeks to maintain exposure across five primary subsectors: health services, medical products, specialty pharmaceuticals, major pharmaceuticals and international markets. Fundamental research focuses on companies with high-quality balance sheets, strong management, and the potential for new products that will lead to above-average growth in revenue and earnings. VGHCX is managed by Wellington Management Company.

VGHCX - Performance

Return Ranking - Trailing

Period VGHCX Return Category Return Low Category Return High Rank in Category (%)
YTD 1.2% 1.8% 36.6% 95.10%
1 Yr -12.2% -25.3% 9.3% 77.45%
3 Yr -3.3%* -17.5% 21.7% 84.31%
5 Yr -1.4%* -11.3% 17.8% 57.84%
10 Yr 5.8%* -1.8% 15.6% 68.24%

* Annualized


Return Ranking - Calendar

Period VGHCX Return Category Return Low Category Return High Rank in Category (%)
2018 -7.3% -25.3% 7.7% 45.10%
2017 11.2% -10.8% 43.9% 74.51%
2016 -16.2% -29.8% 2.6% 56.86%
2015 4.1% -20.4% 13.8% 14.71%
2014 13.1% -5.8% 31.5% 63.27%

Total Return Ranking - Trailing

Period VGHCX Return Category Return Low Category Return High Rank in Category (%)
YTD 1.2% 1.8% 36.6% 95.10%
1 Yr -12.2% -25.3% 12.9% 81.37%
3 Yr -3.3%* -17.5% 24.8% 90.20%
5 Yr -1.4%* -11.3% 19.8% 79.41%
10 Yr 5.8%* -1.8% 18.8% 84.71%

* Annualized


Total Return Ranking - Calendar

Period VGHCX Return Category Return Low Category Return High Rank in Category (%)
2018 -7.3% -25.3% 12.3% 53.92%
2017 11.2% -10.8% 45.8% 85.29%
2016 -16.2% -24.2% 8.7% 69.61%
2015 4.1% -16.6% 15.2% 53.92%
2014 13.1% -5.8% 36.7% 82.65%

NAV & Total Return History

VGHCX - Holdings

Concentration Analysis

VGHCX Category Low Category High VGHCX % Rank
Net Assets 44.3 B 13.8 M 44.7 B 1.96%
Number of Holdings 106 30 392 27.45%
Net Assets in Top 10 17.9 B 6.7 M 18.8 B 1.96%
Weighting of Top 10 39.86% 25.1% 75.2% 59.80%

Top 10 Holdings

  1. AstraZeneca PLC 5.81%

  2. Allergan PLC 5.72%

  3. UnitedHealth Group Inc 5.40%

  4. Bristol-Myers Squibb Company 5.16%

  5. Novartis AG 3.80%

  6. Eli Lilly and Co 3.33%

  7. Abbott Laboratories 2.82%

  8. Boston Scientific Corp 2.76%

  9. Anthem Inc 2.55%

  10. Merck & Co Inc 2.50%


Asset Allocation

Weighting Return Low Return High VGHCX % Rank
Stocks
97.00% 91.85% 103.82% 65.69%
Cash
3.00% 0.00% 5.40% 12.75%
Preferred Stocks
0.00% 0.00% 2.32% 88.24%
Other
0.00% -3.83% 2.75% 84.31%
Convertible Bonds
0.00% 0.00% 0.12% 86.27%
Bonds
0.00% 0.00% 0.66% 89.22%

Stock Sector Breakdown

Weighting Return Low Return High VGHCX % Rank
Healthcare
93.55% 10.92% 99.42% 74.51%
Technology
2.52% 0.00% 62.64% 24.51%
Real Estate
0.18% 0.00% 1.35% 10.78%
Utilities
0.00% 0.00% 0.00% 86.27%
Industrials
0.00% 0.00% 12.61% 91.18%
Financial Services
0.00% 0.00% 5.80% 86.27%
Energy
0.00% 0.00% 0.09% 86.27%
Communication Services
0.00% 0.00% 0.00% 86.27%
Consumer Defense
0.00% 0.00% 0.69% 88.24%
Consumer Cyclical
0.00% 0.00% 8.52% 89.22%
Basic Materials
0.00% 0.00% 1.92% 92.16%

Stock Geographic Breakdown

Weighting Return Low Return High VGHCX % Rank
US
68.47% 60.46% 99.29% 99.02%
Non US
28.53% 0.00% 39.02% 9.80%

VGHCX - Expenses

Operational Fees

VGHCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.34% 0.10% 2.98% 98.04%
Management Fee 0.32% 0.09% 1.25% 2.94%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.01% 0.40% N/A

Sales Fees

VGHCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 2.50% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

VGHCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 0.75% 2.00% N/A

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

VGHCX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 16.00% 0.00% 341.00% 15.69%

VGHCX - Distributions

Dividend Yield Analysis

VGHCX Category Low Category High VGHCX % Rank
Dividend Yield 1.18% 0.00% 0.01% 2.94%

Dividend Distribution Analysis

VGHCX Category Low Category High Category Mode
Dividend Distribution Frequency None Annually Annually Annually

Dividend Payout History


Net Income Ratio Analysis

VGHCX Category Low Category High VGHCX % Rank
Net Income Ratio 1.12% -2.15% 1.48% 3.92%

Capital Gain Distribution Analysis

VGHCX Category Low Category High Capital Mode
Capital Gain Distribution Frequency None Annually Annually Annually

VGHCX - Managers

Jean M. Hynes

Manager

Start Date

Tenure

Tenure Rank

May 29, 2008

11.18

11.2%

Jean M. Hynes, CFA, Senior Managing Director and Global Industry Analyst of Wellington Management, has been involved in portfolio management and securities analysis for the health science portion of the Fund since August 2003. Jean holds a BA in economics from Wellesley College (1991). She joined Wellington Management upon her graduation. She holds the Chartered Financial Analyst designation, and is a member of the CFA Institute and the Boston Security Analysts Society.


Tenure Analysis

Category Low

0.08

Category High

21.8

Category Average

10.26

Category Mode

19.18